ArticleInflammatory bowel diseases2026

Efficacy, Safety, and Pharmacokinetics of Golimumab in Children with Moderately-To-Severely Active Ulcerative Colitis: Results from the PURSUIT 2 Study.

Dan Turner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.